Return on investment in disease management: A review

Ron Z. Goetzel, Ronald J. Ozminkowski, Victor G. Villagra, Jennifer Duffy

Research output: Contribution to journalReview articlepeer-review

Abstract

The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple disease conditions. Some evidence suggests that diabetes programs may save more than they cost, but additional studies are needed. Results are mixed for asthma management programs. Depression management programs cost more than they save in medical expenses, but may save money when considering productivity outcomes.

Original languageEnglish (US)
Pages (from-to)1-19
Number of pages19
JournalHealth Care Financing Review
Volume26
Issue number4
StatePublished - Jun 1 2005
Externally publishedYes

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'Return on investment in disease management: A review'. Together they form a unique fingerprint.

Cite this